NICHD Small Grants Programs
NICHD 小额赠款计划
基本信息
- 批准号:6707003
- 负责人:
- 金额:$ 7.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:HIV infectionsclinical researchdisease /disorder proneness /riskembryo /fetus tissue /cell culturegene mutationgenetic markersgenetic polymorphismhistocompatibility genehuman fetus tissuehuman genetic material taghuman tissueimmunogeneticsimmunopathologylinkage disequilibriumsmajor histocompatibility complexmolecular cloningnucleic acid sequencepediatric AIDSpolymerase chain reactionsingle strand conformation polymorphismstatistics /biometryvertical transmission
项目摘要
DESCRIPTION (provided by applicant): Perinatal transmission accounts for more than 90 percent of HIV-infection in children. A thorough understanding of the molecular and genetics mechanisms of the host immune gene response (such as chemokines, cytokines, HLA polymorphisms) effecting the pathogens and transmission consequences of host-HIV-1 interactions is essential to all aspects of public health for diagnostic, transmission, and prevention strategies. This study is designed to understand the mutational role of HLA-G gene that make HIV-1 infected women more (or less likely) to transmit virus to her infant. HLA-G is non-classical class 1 MHC gene and it is highly expressed in extravillous cytotrophoblast at the maternal fetal interface. Specific aim: To further examine the potential role (s) of the mutation in HLA-G exon 2, which was previously associated to reduced risk in perinatal transmission (Aikhionbare, AIDS 2001,15: 2196-8) and any mutation(s) in HLA-G untranslated region in DNA samples obtained from both Project RETRO-C1, 01 BP 1712, 10 Abidjan Cote d'Ivoire and Perinatal AIDS Collaborative Transmission Study (PACTS), for possibly increase or decrease in the susceptibility of a neonate to HIV-1- perinatal transmission. Approach: DNA samples will be obtained from HIV-1-infected and uninfected mother-child pairs followed as part of Project RETRO-C1, 01 BP 1712, 10 Abidjan Cote d'Ivoire and Perinatal AIDS Collaborative Transmission Study will be screened by the following techniques: WAVETM Nucleic Acid Fragment Analysis, allele-specific polymerase chain reaction (PCR), single strand conformational polymorphism (SSCP), followed by DNA cloning/sequencing. Molecular data from this study will be subjected to Fisher's exact test, Maximum likelihood, Linked disequilibrum parameter, Odd ratio, Relative risk analysis to groups value. Results will furnish new insights into the basic mechanisms of the viral pathogenesis in AIDS, especially the contribution of certain host genetic factors to HIV-1 perinatal infection.
描述(由申请人提供):围产期传播占儿童艾滋病毒感染的90%以上。全面了解宿主免疫基因反应的分子和遗传学机制(如趋化因子、细胞因子、HLA多态性)对宿主- hiv -1相互作用的病原体和传播后果的影响,对公共卫生诊断、传播和预防策略的各个方面至关重要。这项研究旨在了解HLA-G基因的突变作用,使HIV-1感染的妇女更容易(或更不可能)将病毒传播给她的婴儿。HLA-G是一种非经典的1类MHC基因,它在母胎界面的胞外滋养细胞中高度表达。具体目的:进一步研究HLA-G外显子2突变的潜在作用,该突变先前与围产期传播风险降低有关(Aikhionbare, AIDS 2001,15);2196-8)以及来自Project retroc - c1、01 BP 1712、10 Abidjan Cote d' ivire和围产期艾滋病合作传播研究(PACTS)的DNA样本中HLA-G非翻译区的任何突变,可能增加或减少新生儿对HIV-1-围产期传播的易感性。方法:将从hiv -1感染和未感染的母婴对中获得DNA样本,作为项目retroc - c1, 01 BP 1712, 10阿比让科特迪瓦和围产期艾滋病协同传播研究的一部分,将通过以下技术进行筛选:WAVETM核酸片段分析,等位基因特异性聚合酶链反应(PCR),单链构象多态性(SSCP),然后进行DNA克隆/测序。本研究的分子数据将进行Fisher精确检验、最大似然、关联不平衡参数、奇数比、相对风险分析。这些结果将为艾滋病病毒发病的基本机制,特别是某些宿主遗传因素对HIV-1围产期感染的贡献提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Felix O Aikhionbare其他文献
HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission
HLA-G DNA 序列变异和围产期 HIV-1 传播风险
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:2.2
- 作者:
Felix O Aikhionbare;K. Kumaresan;Falah Shamsa;Vincent C. Bond - 通讯作者:
Vincent C. Bond
Felix O Aikhionbare的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Felix O Aikhionbare', 18)}}的其他基金
Colorectal cancer disparities:Racial differences in colorectal adenopolyps and altered expression of Mitochondrial genes
结直肠癌差异:结直肠腺息肉的种族差异和线粒体基因表达的改变
- 批准号:
9280274 - 财政年份:2017
- 资助金额:
$ 7.1万 - 项目类别:
Mitochondrial Genome Analysis to Detect Aggressive Behavior of Premalignant Color
线粒体基因组分析检测癌前颜色的攻击行为
- 批准号:
8339130 - 财政年份:2012
- 资助金额:
$ 7.1万 - 项目类别:
Mitochondrial Genome Analysis to Detect Aggressive Behavior of Premalignant Color
线粒体基因组分析检测癌前颜色的攻击行为
- 批准号:
8536869 - 财政年份:2012
- 资助金额:
$ 7.1万 - 项目类别:
Mitochondrial Genome Analysis to Detect Aggressive Behavior of Premalignant Color
线粒体基因组分析检测癌前颜色的攻击行为
- 批准号:
8700424 - 财政年份:2012
- 资助金额:
$ 7.1万 - 项目类别:
MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA
上皮性浆液性卵巢癌的线粒体基因组分析
- 批准号:
8037199 - 财政年份:2010
- 资助金额:
$ 7.1万 - 项目类别:
MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA
上皮性浆液性卵巢癌的线粒体基因组分析
- 批准号:
7896248 - 财政年份:2010
- 资助金额:
$ 7.1万 - 项目类别:
Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors
线粒体基因组改变在上皮性卵巢肿瘤中的作用
- 批准号:
7688902 - 财政年份:2009
- 资助金额:
$ 7.1万 - 项目类别:
Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors
线粒体基因组改变在上皮性卵巢肿瘤中的作用
- 批准号:
7943124 - 财政年份:2009
- 资助金额:
$ 7.1万 - 项目类别:
NICHD Small Grants Programs--Perinatal HIV Transmission
NICHD 小额赠款计划——围产期艾滋病毒传播
- 批准号:
6653673 - 财政年份:2003
- 资助金额:
$ 7.1万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 7.1万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 7.1万 - 项目类别: